Concepedia

Publication | Open Access

SAR110894, a potent histamine H3‐receptor antagonist, displays disease‐modifying activity in a transgenic mouse model of tauopathy

DOIFull Paper Access

19

Citations

35

References

2016

Year

Philippe Delay‐Goyet, Véronique Blanchard, Nathalie Schussler, Mati Lopez‐Grancha, Jean Ménager, Véronique Mary, Eric Sultan, Armelle Buzy, Jean‐Claude Guillemot, Jeanne Stemmelin,
Alzheimer s & Dementia Translational Research & Clinical Interventions

Abstract

Long-term SAR110894 treatment could have potential disease modifying activity in neurodegenerative tauopathies.

References

YearCitations

Page 1